These criteria selected HCC patients for LT in the absence of portal vein tumor invasion and with either HCC ≤ 8 cm in diameter or with HCC ≥ 8 cm in diameter but with concurrent AFP serum levels < 400 ng/mL and histological grade I or II. This evidence concerns the gene AFP and hepatocellular carcinoma.